<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The following article is a case report of a 7-year-old patient who developed bilateral <z:hpo ids='HP_0001085'>papilledema</z:hpo> while taking Zoloft (<z:chebi fb="0" ids="9123">sertraline</z:chebi> <z:chebi fb="16" ids="36807">hydrochloride</z:chebi>) for an <z:hpo ids='HP_0000739'>anxiety</z:hpo> disorder </plain></SENT>
<SENT sid="1" pm="."><plain>The incidental discovery of bilateral optic disc elevation early in her course of therapy as well as its rapid resolution after cessation of Zoloft are described </plain></SENT>
<SENT sid="2" pm="."><plain>The absence of neurologic disease or visual system pathology in this patient led to a diagnosis of drug-induced <z:hpo ids='HP_0001085'>papilledema</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Neuroimaging was suggestive of <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Although many drugs have been implicated in the development of <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e>, there have been no previous reports of <z:hpo ids='HP_0001085'>papilledema</z:hpo> or <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> related to the use of Zoloft </plain></SENT>
</text></document>